These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31885678)

  • 21. Novel two-phase sampling designs for studying binary outcomes.
    Wang L; Williams ML; Chen Y; Chen J
    Biometrics; 2020 Mar; 76(1):210-223. PubMed ID: 31449330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing Heterogeneity of Treatment Effects in Observational Studies.
    Robertson SE; Leith A; Schmid CH; Dahabreh IJ
    Am J Epidemiol; 2021 Jun; 190(6):1088-1100. PubMed ID: 33083822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The sum of standardized residuals: Goodness-of-fit test for binary response models.
    Chen L; Sui Y; Song C; Rempala GA
    Stat Med; 2018 May; 37(11):1932-1941. PubMed ID: 29579778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous time Markov models for binary longitudinal data.
    Jones RH; Xu S; Grunwald GK
    Biom J; 2006 Jun; 48(3):411-9. PubMed ID: 16845905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of graphical diagnostics for assessing goodness of fit of logistic regression models.
    Pavan Kumar VV; Duffull SB
    J Pharmacokinet Pharmacodyn; 2011 Apr; 38(2):205-22. PubMed ID: 21153868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A methodological framework for model selection in interrupted time series studies.
    Lopez Bernal J; Soumerai S; Gasparrini A
    J Clin Epidemiol; 2018 Nov; 103():82-91. PubMed ID: 29885427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of an outcome using trajectories estimated from a linear mixed model.
    Maruyama N; Takahashi F; Takeuchi M
    J Biopharm Stat; 2009 Sep; 19(5):779-90. PubMed ID: 20183443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of exclusion, imputation and modelling of missing binary outcome data in frequentist network meta-analysis.
    Spineli LM; Kalyvas C
    BMC Med Res Methodol; 2020 Feb; 20(1):48. PubMed ID: 32111167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fragility non-hip fracture patients are at risk.
    Gosch M; Druml T; Nicholas JA; Hoffmann-Weltin Y; Roth T; Zegg M; Blauth M; Kammerlander C
    Arch Orthop Trauma Surg; 2015 Jan; 135(1):69-77. PubMed ID: 25412880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Joint modelling of time-to-event and multivariate longitudinal outcomes: recent developments and issues.
    Hickey GL; Philipson P; Jorgensen A; Kolamunnage-Dona R
    BMC Med Res Methodol; 2016 Sep; 16(1):117. PubMed ID: 27604810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 30-day mortality after hip fracture surgery: Influence of postoperative factors.
    Blanco JF; da Casa C; Pablos-Hernández C; González-Ramírez A; Julián-Enríquez JM; Díaz-Álvarez A
    PLoS One; 2021; 16(2):e0246963. PubMed ID: 33592047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modelling hospital outcome: problems with endogeneity.
    Moran JL; Santamaria JD; Duke GJ;
    BMC Med Res Methodol; 2021 Jun; 21(1):124. PubMed ID: 34154530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of bundled payments on hip fracture outcomes: a nationwide population-based study.
    Tung YC; Chang HY; Chang GM
    Int J Qual Health Care; 2018 Feb; 30(1):23-31. PubMed ID: 29194494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of Nottingham Hip Fracture score as a predictor of 1-year mortality risk for periprosthetic hip fractures.
    Grewal MUS; Bawale MR; Singh PB; Sandiford MA; Samsani MS
    Injury; 2022 Feb; 53(2):610-614. PubMed ID: 34986978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dangers of ignoring underlying trends in before-and-after studies - A cautionary tale using hip fracture mortality data.
    Cheik-Hussein M; Harris IA; Lewin AM
    J Orthop Surg (Hong Kong); 2020; 28(2):2309499020935996. PubMed ID: 32618223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On outcome-dependent sampling designs for longitudinal binary response data with time-varying covariates.
    Schildcrout JS; Heagerty PJ
    Biostatistics; 2008 Oct; 9(4):735-49. PubMed ID: 18372397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal Joint Modelling of Ordinal and Overdispersed Count Outcomes: A Bridge Distribution for the Ordinal Random Intercept.
    Amini P; Moghimbeigi A; Zayeri F; Tapak L; Maroufizadeh S; Verbeke G
    Comput Math Methods Med; 2021; 2021():5521881. PubMed ID: 33763151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors for 1-year mortality following hip fracture: a retrospective review of 465 consecutive patients.
    Heyes GJ; Tucker A; Marley D; Foster A
    Eur J Trauma Emerg Surg; 2017 Feb; 43(1):113-119. PubMed ID: 26260068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of renal dialysis and hip fracture sites on the 10-year mortality of elderly hip fracture patients: A nationwide population-based observational study.
    Hung LW; Hwang YT; Huang GS; Liang CC; Lin J
    Medicine (Baltimore); 2017 Sep; 96(37):e7618. PubMed ID: 28906354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods.
    Hernández Alava M; Wailoo A; Pudney S; Gray L; Manca A
    Health Technol Assess; 2020 Jun; 24(34):1-68. PubMed ID: 32613941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.